StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA): a Phase II Trial of Non-Invasive Treatment of Medically Refractory Patients
Sponsor: University Health Network, Toronto
This NA trial investigates Cardiac Arrhythmia and is currently actively recruiting participants. University Health Network, Toronto leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Mar 2026 — Present [monthly]
Recruiting NA
-
Mar 2025 — Mar 2026 [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Nov 2023 — Apr 2024 [monthly]
Recruiting NA
-
May 2023 — Nov 2023 [monthly]
Recruiting NA
-
Dec 2022 — May 2023 [monthly]
Recruiting NA
-
Nov 2022 — Dec 2022 [monthly]
Recruiting NA
-
Apr 2022 — Nov 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2021 — Apr 2022 [monthly]
Not Yet Recruiting NA
-
May 2021 — Nov 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .